国药控股:国药股份2024年度归母净利润20亿元 同比下降6.8%

新浪港股
20 Mar
热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易
客户端

  国药控股(01099)发布公告,国药股份(600511.SH)于2024年度实现营业收入505.97亿元(人民币,下同),同比增长1.81%;归属于上市公司股东的净利润20亿元,同比下降6.80%;基本每股收益2.6509元,拟每10股派发现金股利8.00元(含税)。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10